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BACKGROUND
Up to 60% of the patients with known adenomatous pol­
yposis coli may present hyperostosis of the skull and 
facial bones, and/or a susceptibility to fibromas. This is 
known as the Gardner’s syndrome, and is considered as 
an allelic variant of familial adenomatous polyposis 
(FAP). Also, although very rare, an adenomatous polyp­
osis coli may occur with malignant tumors of the central 
nervous system, known as Turcot syndrome. If both syn­
dromes are different phenotypic presentation of FAP, this 
would explain a simultaneous occurrence.
METHOD
We report the history of a patient who showed clinical 
signs of the simultaneous occurrence of both Gardner’s 
and Turcot syndromes. The syndromes are compared, 
and in view of the literature, a genetic explanation for the 
concomitant occurrence is discussed.
RESULTS
Evidence obtained from the literature to consider Turcot 
syndrome as a phenotype of FAP is as follows:
(1) The occurrence of Gardner’s and Turcot syndromes 
in one family, but in different members;
(2) The presence of congenital hypertrophic retinal pig­
mented epithelium (CHRPE), which correlates with 
the expression of polyps in FAP patients, in both 
syndromes;
(3) Linkage of the Turcot phenotype to the adenomatous 
polyposis coli locus by genetic markers.
Evidence obtained from this case report indicates that 
there is a manifestation of both syndromes in one patient 
together with a positive family history for FAP.
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C O N C LU SIO N
This concomitant occurrence of both Gardner’s and Tur­
cot syndromes in one patient clinically supports genetic 
and ophthalmic investigation to consider Turcot syn­
drome (like Gardner’s syndrome) as a phenotypic variant 
of FAP. Patients with FAP should be examined for the 
presence of Gardner’s syndrome. In case a Gardner’s 
syndrome is suspected, a computed tomography scan of 
the brain is recommended because of the possible exis­
tence of a simultaneous Turcot syndrome.
KEY WORDS
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G ardner’s and Turcot syndrom e are hereditary 
conditions with adenom atous polyposis coli 
in common. In addition to this gastrointestinal man­
ifestation, the Gardner's syndrom e presents with 
hyperostosis of the skull, skull base, or facial bones, 
and (sub)cutaneous lesions like epidermoid cysts 
or fibromas [4], Desmoid tum ors [6], various dental 
abnormalities [5], and extracolonic carcinomas 
[3,18] can also be part of the  syndrome.
Turcot syndrome is known as the  simultaneous 
appearance of adenom atous polyposis coli and ma­
lignant neuroepithelial tum ors, in particular glio­
mas and medulloblastomas [24]. This syndrom e is 
very rare; less than 50 patients have been described 
[8 ].
In this article, we presen t a patient who is likely to 
have both  syndromes. Although the simultaneous 
presence of Gardner’s and Turcot syndromes among 
members of one family has been described [11], the 
simultaneous occurrence of both syndromes in one 
patient has not previously been reported.
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WM X ray of skull: Hyperostosis of the right part of the 
U  skull base (arrow).
C a s e  R e p o r t
A 19-year-old man complained of blood loss during 
defecation. Colonoscopy followed by colectomy re­
vealed approximately 25 villous adenomas with a 
maximal size of 5 cm. Histologic verification showed 
marked adenom atous changes without infiltrative 
growth, corresponding to adenomatous polyposis 
coli.
Two months later, a relaparotomy had to be per­
formed, as the  small bowel was obstructed by ex­
tensive adhesions. Five months later, the patient 
complained of headache, nausea, and diplopia. Neu­
rologic examination showed papilledema in both 
eyes and a slight right-sided facial palsy. At the left 
parietal region of the skull, a large bony elevation 
was found.
Plain x rays of the skull showed three lucent 
lesions in the parietal and frontal bone, and a large 
density on the left parietal bone and right skull 
base, which were suggestive of hyperostosis of the 
skull (Figure 1). The magnetic resonance imaging 
(MRI) scan showed a large hyperintensive intrace­
rebral tumor in the left frontal lobe and an obstruc­
tive hydrocephalus (Figure 2).
A left-sided frontotemporal craniotomy was per­
formed, and a large part of the tumor was removed. 
Histology showed a grade II protoplasmatic astro-
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Jffjk MRI of the brain (TR, 2080 ms; TE, 30 ms) showing a 
d  large area with increased signal intensity at the me­
dial side of the left frontal lobe.
cytoma according to Kernohan [9]. Initially, the 
postoperative period was uneventful. However, 4 
months later a ventriculoperitoneal drain was 
placed in th e  right frontal horn because of hydro­
cephalus. After that, the patient was able to per­
form his daily work.
Two years later, due to tumor recurrence and 
edema, a recraniotomy was done. Histology of the 
tumor was similar to the previously found grade II 
astrocytoma. In addition, radiotherapy was given to 
a total dose of 54 gray.
After an initial improvement, the patient deterio­
rated several months later. MRI investigation again 
showed growth tendency and edema at the original 
tumor location and also infiltration, tumor forma­
tion, and edem a in the contralateral hemisphere. As 
no additional treatment could be offered, he died 
several m onths later.
At the tim e of the second operation, tumor cells 
were cultured for cytogenetic investigation, which 
did not show  any chromosomal abnormality (ap­
parently norm al male karotype, 46 XY).
The family was screened for familial adenoma­
tous polyposis coli. Colonic cancer was present in 
the paternal grandfather (died at 41 yrs), the  pater­
Simultaneous Occurrence of Turcot and Gardner’s Syndromes Surg Neurol 2 1 5
1996;45:213-8
Gardner’s versus Turcot syndrome.
Gardner’s This Case Turcot
Mean age on presentation 27 years 19 years 19 years
Adenomatous polyposis +
Average no. of polyps 1000 25 20-100
Size <5 mm + + + +
Size >30 mm — + +
Small intestine involved + — -------
Malignant transfer (years) + ?m
Osteomas + + -------
Gliomas of the central nervous system — + * n |  m
including medulloblastomas
Soft tissue tumors like epidermoid ~ h + —
cysts, desmoid tumors, and 
fibromas
Various dental abnormalities + — —
Extracolonic carcinomas (adrenal — —
region and thyroid)
Congenital hypertrophic retinal + ?«
pigmented epithelium (CHRPE)
Synonyms Gardner-Richards 
Fitzgeral d-Gardner 
Hereditary polyposis 
and osteomatosis.
Turcot~Després~St. Pierre
Glioma-polyposis
Colon polyposis CNS tumor.
Data are obtained from literature (see text).
nal father (died at 71 yrs), and the maternal father 
(died at 76 yrs). Neither the parent of our patient 
nor his older sister had signs of polyposis or co­
lonic cancer. Adenomatous polyposis coli was only 
found in the patient’s younger sister. Neither her 
neurologic condition nor the MRI scan shows any 
pathology until now.
D i s c u s s i o n
In this patient, the following details were present:
(1) Adenomatous polyposis coli at an age of 19 
years,
(2) hyperostosis of the skull and skull base;
(3) a low-grade astrocytoma in the left frontal lobe;
(4) extensive adhesions after laparotomy.
1. Both Gardner’s and Turcot syndromes present 
an adenomatous polyposis coli [19]. The mean 
age of presentation of the Gardner’s syndrome is 
halfway through the third decade [12], whereas 
in the Turcot syndrome it is at the end of the  
second decade [8]. The polyps of the Gardner’s 
syndrome are identical to those in the familial 
adenomatous polyposis coli syndrome (FAP). 
They are small (almost always <  5 mm), numer­
ous (average of 1000), and not restricted to the  
colon [2]. In Turcot syndrome, polyps are larger 
in size (frequently >  3 cm), less numerous (nor­
mally 20-100), and usually limited to the colon 
[7], The polyps of both syndromes undergo ma­
lignant transformation, as a rule several years 
after the first gastrointestinal manifestations. 
The main symptoms and differences are summa­
rized in Table 1.
When the patient presented at the  age of 19 
years, approximately 25 adenom atous polyps 
(maximum size, 5 cm) were found. This atypical 
adenomatous polyposis coli corresponds most 
to Turcot syndrome.
2. Hyperostosis is a characteristic finding in the 
Gardner’s syndrome. Separate tum ors (osteo­
mas) or protrusions from already existing bone 
structures, such as the skull and skull base as 
found in the presented patient, may occur. Man­
dible, sphenoid, and maxilla are also frequently 
affected [4]. These tum ors rarely undergo malig­
nant degeneration. In Turcot syndrome, there 
are no reports of such bone tum ors.
3. Malignant tumors of the central nervous system 
are essential findings in Turcot syndrome. The 
syndrome should be restricted  to those  cases in 
which adenomatous polyposis coli is coupled 
with the brain tumors, as originally described by 
Turcot in 1959 [24], i.e., gliomas including medul- 
loblastomas [8, 20]. The time between the  gas­
trointestinal complaints and the onset of these 
tum ors usually does not exceed 5 years. Neural
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tumors, which present more that 20 years after 
the initial symptoms of adenomatous polyposis 
coli, must therefore be considered as coinciden­
tal tumors [8]. Low-grade astrocytoma, as in the 
presented patients, is a regularly found tumor in 
Turcot syndrome.
4. Mesenteric fibromatosis or desmoid tumor for­
mation following abdominal surgery and leading 
to postoperative bowel obstruction is a well 
known symptom of Gardner’s syndrome or FAP 
in general [6]. The etiology of the insufficient 
regulation of connective tissue growth is not 
clear, although (surgical) trauma, pregnancy, 
and other hormonal effects have been mentioned 
as contributing to the formation and growth be­
havior of these tumors [6]. A similar process 
with extensive adhesions was found in the pa­
tient we describe.
Summarizing, the  type, number, and distribution 
of adenomatous polyps, together with a grade-2 
astrocytom a are indicative of full-blown Turcot syn­
drome. However, hyperostosis and fibromatosis 
with adenomatous polyposis coli also present in 
the same patient, comply with the definition of 
Gardner’s syndrome. So in this patient the clinical 
signs of Gardner’s and Turcot syndrome occur si­
multaneously.
As both syndromes presen t an adenomatous pol­
yposis coli, it may be relevant to find out whether 
Gardner’s and Turcot syndromes are different phe­
notypic presentations of the familial adenomatous 
polyposis syndrome (FAP). If so, this would explain 
the  simultaneous occurrence of both syndromes in 
the presented patient.
The Gardner’s syndrom e is an allelic variant of 
the FAP, as both syndrom es show coupled trans­
mission with the sam e markers at chromosome 5q 
[13]. After the  adenom atous polyposis coli (APC) 
gene was mapped at chromosome 5q21 and cloned
[10], it was found that both syndromes showed 
germline mutations at the APC locus [16]. FAP has 
an autosomal dominant mode of inheritance with 
high penetrance. For the Turcot syndrome, both an 
autosomal dominant and recessive mode of inheri­
tance have been advocated, but because of the very 
low incidence of the syndrome, no common opinion 
of inheritance can be given yet.
In general, the num ber and size of the polyps 
differ in the Gardner’s and Turcot syndrome. Na- 
gase et al found a correlation between the location 
of the mutation in the  APC gene at chromosome 5q, 
and the number of polyps in FAP patients has been 
reported [15]. One can imagine that the location of 
the  mutation in the  APC gene also influences the
formation of the extracolonic (brain) tumors. This 
may reduce the Gardner’s and Turcot syndrome to 
allelic variants of FAP caused by mutations at dif­
ferent locations within the APC gene. Some muta­
tions may even give rise to a mixed phenotype, as in 
this case.
This theory is supported by the finding of con­
genital hypertrophic retinal pigmented epithelium 
(CHRPE) in a patient with a Turcot syndrome [14], 
As the presence of CHPRE lesions correlates with 
development of polyps in both the FAP and the 
Gardner’s syndrome [17,23], this also gives evi­
dence to consider the Turcot syndrome as an allelic 
variant of FAP.
Several authors’ observations of “polyposis coli” 
families in which the Gardner’s and the Turcot syn­
drome occur in the same family, but in different 
members [11,20], also support this theory.
Regarding the patient’s family, only the younger 
sister was affected by an adenomatous polyposis 
coli. It was known that the fathers of both parents 
and the paternal grandfather suffered from colonic 
cancer, but no additional information is available. 
Apart from his younger sister no neuroradiologic 
examinations of the family members were per­
formed.
As a rule, syndromes with an autosomal domi­
nant inheritance like FAP show a very variable ex­
pression. This means that a carrier of an abnormal 
or mutated gene need not always be recognized.
Therefore, the most obvious interpretation of 
this case would be a paternal familial inheritance of 
FAP, without penetrance or with a minimal expres­
sion in the father of the patient. The predisposing 
mutation in the APC gene may reveal both a Gard­
ner’s and Turcot phenotype.
By using a panel of FAP-linked DNA markers, Tops 
et al suggested that involvement of the APC gene at 
chromosome 5q21-q22 in the family of the pre­
sented patient was very unlikely [22]. However, the 
marker currently accepted for clinical determina­
tion of linkage to mutations at the APC locus 
(D55346) [21] was not part of the markers that 
Tops et al applied in their study. Lasser et al used 
this nearest-to-the-APC-locus-located polymorphic 
marker in analyzing a 12-member family in which 
three individuals had Gardner’s and two had Turcot 
syndrome [11]. Highly suggestive evidence for link­
age of the Turcot phenotype to the APC locus was 
found in this study. Reexamination of the presented 
patient and his family by using marker D5S346 may 
also show evidence for linkage to the APC locus.
The concomitant occurrence of Gardner’s and 
Turcot syndrome in one patient can be seen as the 
ultimate evidence for what was already plausible by
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genetic [11] and ophthalmic [14] investigations, i.e., 
the Turcot syndrome being a variant phenotypic 
expression of the APC gene. In this respect, the 
patient’s sister may develop a similar syndrome.
Based on the fact that after careful examination 
for extracolonic manifestations, 15%-60% of the pa­
tients initially presenting with FAP meet the criteria 
of Gardner’s syndrome [1,2], supported by reports 
of Gardner’s and Turcot syndrome in one family, we 
recommend a thorough physical and neurologic ex­
amination and plain x rays of the skull for these 
patients. A computed tomography scan (contrast 
enhanced) of the skull and brain is highly recom­
mended in those patients with adenomatous polyp­
osis coli in which osteomas are found during phys­
ical examination or on plain x rays of th e  skull.
Furthermore, children and young adults of a fam­
ily with a history of FAP should have a complete 
ophthalmic examination as the finding of CHRPE 
patches indicates an increased risk for the devel­
opment of gastrointestinal polyps and tum ors of the 
central nervous system [14,23].
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COMMENTARY
The authors describe a patient who had features of 
Gardner’s syndrome and Turcot syndrome, in that 
the patient had adenom atous polyposis of the colon 
in addition to a left frontal lobe astrocytoma, Grade 
II (Turcot syndrome), and by plain x rays of the 
skull, left parietal bone and right skull-base hyper­
ostosis (Gardner’s syndrome). This is a most inter­
esting case for the occurrence of these two syn­
dromes, there was a positive family history in that 
the paternal grandfather died of colon cancer, and 
it was present in the paternal father and maternal 
father. Both parents of the propositus and his older 
sister were negative for colon cancer. The patient 
may have an autosomal recessive form of this dis­
ease complex and could represent a new and 
unique inherited form of astrocytoma. Additional 
studies for a mutation at 5q21q22 would be of great 
interest in this family as the gene for familial adeno­
matous polyposis coli has been mapped to that 
locus.
Roger N. Rosenberg, M.D.
Dallas, Texas
An explosive growth in the field of medical genetics 
has occurred in the last years. The list of genes 
responsible for various human diseases and identi­
fied and studied at the molecular level increases 
monthly. This development brings about major re­
visions in thinking about some conditions that had 
been considered to be separate clinical entities. 
Mutations in different regions of the same gene can 
cause quite different symptoms. For instance, we 
now know that Duchenne muscular dystrophy and 
Becker muscular dystrophy result from mutations 
of different domains of the same gene. The same is 
true for a variety of craniosynostosis conditions 
described as Pfeiffer syndrome, Crouzon syndrome, 
Jackson-Weiss syndrome, and Apert syndrome [4]. 
These findings come from converging genetic evi­
dence and careful clinical examination of marginal 
presentations of related syndromes. From this
standpoint, the paper by Koot et al presents an 
important link between familial adenomatous pol­
yposis (FAP), Gardner’s syndrome, and Turcot syn­
drome. FAP is a widespread inherited condition. 
The gene responsible for FAP, the so-called APC- 
antioncogene, is located at the locus 5q22,l and 
was cloned 4 years ago [2]. The function of the 
protein encoded by the gene is unknown. Gardner’s 
syndrome is described as a variant of FAP with 
craniofacial malformations; Turcot syndrome is de­
scribed as a variant of FAP with malignant tumors of 
the central nervous system. There are data that 
show that Gardner's syndrome maps to the same 
location on chromosome 5 [1] as does Turcot syn­
drome [3], Another symptom that occurs concom­
itantly with FAP and is determined by mutations in 
the ACP gene is congenital hypertrophy of the ret­
inal pigment epithelium (CHRPE), and the expres­
sion of this symptom was correlated with specific 
mutations in the APC gene [5]. There is a good 
chance that all the conditions listed above are 
caused by mutations in the same gene. The paper 
by Koot fills the missing clinical link, demonstrating 
that these can occur together. The paper strongly 
suggests monitoring patients with any manifesta­
tions of these three syndromes for other related 
symptoms, and this recommendation is supported 
by genetic evidence.
Alexander Kolchinsky, Ph.D*
Chicago, Illinois
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